Premier Biomedical, Inc. (OTCMKTS:BIEI) Short Interest Update

Premier Biomedical, Inc. (OTCMKTS:BIEI) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totaling 598,286 shares, a growth of 3,933.5% from the April 30th total of 14,833 shares. Based on an average trading volume of 92,722,395 shares, the short-interest ratio is presently 0.0 days.

Premier Biomedical Trading Down 15.4%

Shares of BIEI opened at $0.00 on Thursday. Premier Biomedical has a twelve month low of $0.00 and a twelve month high of $0.00.

Premier Biomedical Company Profile

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.